Media Database
>
Vineeta Agarwala

Vineeta Agarwala

Author at Andreessen Horowitz at Ben's Blog

Contact this person
Email address
v*****@*******.comGet email address
Influence score
36
Location
United States
Languages
  • English
Covering topics

    View more media outlets and journalists by signing up to Prowly

    View latest data and reach out all from one place
    Sign up for free

    Recent Articles

    a16z.com

    Investing in GC Therapeutics

    GCTx is flipping the entire iPSC differentiation paradigm on its head. Rather than manually iterating through a limited set of differentiation protocols, the Human TFome technology platform instead deploys large-scale combinatorial screening to discover new hypotheses and new protocols that are as-yet unknown to even the best biologists.
    a16z.com

    Investing in Valar Labs - Andreessen Horowitz

    There is perhaps nowhere more exciting or impactful to build such tools than in healthcare—where progress is often so constrained by human expertise. Valar Labs is taking on exactly this challenge, and bringing AI into the toolbox for better cancer care.
    a16z.com

    Dark Genome Hunting with Rosana Kapeller and Marty Taylor - Andrees...

    Rosana Kapeller, CEO of Rome Therapeutics, and Marty Taylor, physician-scientist at Harvard Medical School, join Vineeta Agarwala, general partner, and Bryan Faust, investment partner at a16z Bio + Health.
    a16z.com

    Gate Unveiling with Jordi Mata-Fink - Andreessen Horowitz

    Jordi Mata-Fink, PhD, cofounder of Gate Bioscience, joins Vineeta Agarwala and Ben Portney of a16z Bio + Health.In this episode, Jordi discusses how he and his cofounders are working to commercialize a novel class of therapeutics, termed “molecular gates.”
    a16z.com

    Drugging the Undruggable with Greg Verdine - Andreessen Horowitz

    Greg Verdine, PhD, is a leader in the discovery, development, and commercialization of new drug modalities, a repeat founder, and the newest venture partner at a16z Bio + Health. He is joined by Vineeta Agarwala and Jorge Conde, general partners at a16z Bio + Health.
    a16z.com

    Bio Eats World: From Faculty to Founder - Andreessen Horowitz

    The decision to stay in or leave academia is a common one contemplated by academic founders—and it’s important to gauge what your individual goals are when making the decision.
    a16z.com

    AI is Here. Now What? with Eric Topol - Andreessen Horowitz

    Eric Topol joins a16z Bio + Health general partners Vijay Pande and Vineeta Agarwala and editorial lead Olivia Webb to talk about where AI in healthcare is going, where AI can help patients and providers the most, and what needs to happen to achieve widespread adoption.
    a16z.com

    Deploying AI Platforms to Identify Sepsis with Neri Cohen and Suchi...

    Featuring Suchi Saria, PhD, and the CEO of Bayesian Health; Neri Cohen, MD, PhD, as well as a collaborator with Bayesian Health; and Vineeta Agarwala, MD, PhD, and a16z general partner. Hosted by Olivia Webb.
    a16z.com

    A reading list for biotech’s beginnings; Swapping data for doses; C...

    In this edition of the a16z bio newsletter we’ve got a reading list of books covering biotech’s beginning, plus much more